questionsmedicales.fr
Maladies urogénitales
Maladies de l'appareil urogénital féminin et complications de la grossesse
Complications de la grossesse
Complications tumorales de la grossesse
Tumeurs trophoblastiques
Tumeurs trophoblastiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Néoplasmes trophoblastiques
Diagnostic médical
Échographie
Néoplasmes trophoblastiques
Symptômes
Néoplasmes trophoblastiques
IRM
Néoplasmes trophoblastiques
Symptômes
5
Symptômes
Néoplasmes trophoblastiques
Douleur abdominale
Néoplasmes trophoblastiques
Fatigue
Néoplasmes trophoblastiques
Nausées
Néoplasmes trophoblastiques
Symptômes
Néoplasmes trophoblastiques
Prévention
5
Suivi médical
Néoplasmes trophoblastiques
Antécédents familiaux
Facteurs de risque
Grossesses multiples
Facteurs de risque
Suivi prénatal
Santé maternelle
Traitements
5
Chimiothérapie
Néoplasmes trophoblastiques
Chirurgie
Néoplasmes trophoblastiques
Effets secondaires
Chimiothérapie
Radiothérapie
Néoplasmes trophoblastiques
Complications
5
Complications
Néoplasmes trophoblastiques
Mortalité
Néoplasmes trophoblastiques
Métastases
Néoplasmes trophoblastiques
Santé mentale
Néoplasmes trophoblastiques
Facteurs de risque
5
Facteurs de risque
Grossesse molaire
Antécédents médicaux
Facteurs de risque
Tabagisme
Facteurs de risque
Facteurs environnementaux
Néoplasmes trophoblastiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs trophoblastiques : Questions médicales les plus fréquentes",
"headline": "Tumeurs trophoblastiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs trophoblastiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-12",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs trophoblastiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Complications tumorales de la grossesse",
"url": "https://questionsmedicales.fr/mesh/D011252",
"about": {
"@type": "MedicalCondition",
"name": "Complications tumorales de la grossesse",
"code": {
"@type": "MedicalCode",
"code": "D011252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.050.703.720"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Choriocarcinome",
"alternateName": "Choriocarcinoma",
"url": "https://questionsmedicales.fr/mesh/D002822",
"about": {
"@type": "MedicalCondition",
"name": "Choriocarcinome",
"code": {
"@type": "MedicalCode",
"code": "D002822",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.050.703.720.949.208"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Choriocarcinome non gestationnel",
"alternateName": "Choriocarcinoma, Non-gestational",
"url": "https://questionsmedicales.fr/mesh/D031954",
"about": {
"@type": "MedicalCondition",
"name": "Choriocarcinome non gestationnel",
"code": {
"@type": "MedicalCode",
"code": "D031954",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.050.703.720.949.208.438"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeur trophoblastique du site d'implantation placentaire",
"alternateName": "Trophoblastic Tumor, Placental Site",
"url": "https://questionsmedicales.fr/mesh/D018245",
"about": {
"@type": "MedicalCondition",
"name": "Tumeur trophoblastique du site d'implantation placentaire",
"code": {
"@type": "MedicalCode",
"code": "D018245",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.050.703.720.949.208.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie trophoblastique gestationnelle",
"alternateName": "Gestational Trophoblastic Disease",
"url": "https://questionsmedicales.fr/mesh/D031901",
"about": {
"@type": "MedicalCondition",
"name": "Maladie trophoblastique gestationnelle",
"code": {
"@type": "MedicalCode",
"code": "D031901",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.050.703.720.949.416"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Môle hydatiforme",
"alternateName": "Hydatidiform Mole",
"url": "https://questionsmedicales.fr/mesh/D006828",
"about": {
"@type": "MedicalCondition",
"name": "Môle hydatiforme",
"code": {
"@type": "MedicalCode",
"code": "D006828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.050.703.720.949.416.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Môle invasive",
"alternateName": "Hydatidiform Mole, Invasive",
"url": "https://questionsmedicales.fr/mesh/D002820",
"about": {
"@type": "MedicalCondition",
"name": "Môle invasive",
"code": {
"@type": "MedicalCode",
"code": "D002820",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.050.703.720.949.416.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Môle invasive",
"alternateName": "Hydatidiform Mole, Invasive",
"url": "https://questionsmedicales.fr/mesh/D002820",
"about": {
"@type": "MedicalCondition",
"name": "Môle invasive",
"code": {
"@type": "MedicalCode",
"code": "D002820",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.050.703.720.949.416.875.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs trophoblastiques",
"alternateName": "Trophoblastic Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D014328",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Maryam Shahi",
"url": "https://questionsmedicales.fr/author/Maryam%20Shahi",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA. Shahi.Maryam@mayo.edu."
}
},
{
"@type": "Person",
"name": "Wendy Allen-Rhoades",
"url": "https://questionsmedicales.fr/author/Wendy%20Allen-Rhoades",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Mayo Clinic, Rochester, MN, USA."
}
},
{
"@type": "Person",
"name": "Michael B Ishitani",
"url": "https://questionsmedicales.fr/author/Michael%20B%20Ishitani",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatric Surgery, Mayo Clinic, Rochester, MN, USA."
}
},
{
"@type": "Person",
"name": "Kevin M Elias",
"url": "https://questionsmedicales.fr/author/Kevin%20M%20Elias",
"affiliation": {
"@type": "Organization",
"name": "Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Dana-Farber Cancer Institute, MA, USA."
}
},
{
"@type": "Person",
"name": "Ross S Berkowitz",
"url": "https://questionsmedicales.fr/author/Ross%20S%20Berkowitz",
"affiliation": {
"@type": "Organization",
"name": "Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Dana-Farber Cancer Institute, MA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The complexity of female orgasm and ejaculation.",
"datePublished": "2022-10-08",
"url": "https://questionsmedicales.fr/article/36208324",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-022-06810-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Orgasm Rating Scale and Bodily Sensations of Orgasm Scale: Validation for Use With Pre, Peri, and Post-Menopausal Women.",
"datePublished": "2022-05-06",
"url": "https://questionsmedicales.fr/article/35527103",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jsxm.2022.03.621"
}
},
{
"@type": "ScholarlyArticle",
"name": "Does Clitoral Knowledge Translate into Orgasm? The Interplay Between Clitoral Knowledge, Gendered Sexual Scripts, and Orgasm Experience.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36411727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0092623X.2022.2147112"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of the Italian version of the Orgasmic Perception Questionnaire (OPQ).",
"datePublished": "2023-10-24",
"url": "https://questionsmedicales.fr/article/37874816",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0288850"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the Subjective Orgasm Experience Through Sexual Context, Gender, and Sexual Orientation.",
"datePublished": "2022-12-12",
"url": "https://questionsmedicales.fr/article/36508069",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10508-022-02493-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies urogénitales",
"item": "https://questionsmedicales.fr/mesh/D000091642"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de l'appareil urogénital féminin et complications de la grossesse",
"item": "https://questionsmedicales.fr/mesh/D005261"
},
{
"@type": "ListItem",
"position": 4,
"name": "Complications de la grossesse",
"item": "https://questionsmedicales.fr/mesh/D011248"
},
{
"@type": "ListItem",
"position": 5,
"name": "Complications tumorales de la grossesse",
"item": "https://questionsmedicales.fr/mesh/D011252"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tumeurs trophoblastiques",
"item": "https://questionsmedicales.fr/mesh/D014328"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs trophoblastiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs trophoblastiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs trophoblastiques",
"description": "Comment diagnostique-t-on une tumeur trophoblastique ?\nQuels marqueurs tumoraux sont utilisés ?\nLes échographies sont-elles utiles ?\nQuand faut-il suspecter une tumeur trophoblastique ?\nPeut-on utiliser l'IRM pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Orgasm#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs trophoblastiques",
"description": "Quels sont les symptômes courants ?\nLes tumeurs trophoblastiques causent-elles des douleurs ?\nY a-t-il des symptômes systémiques ?\nLes nausées sont-elles fréquentes ?\nPeut-on avoir des symptômes sans grossesse récente ?",
"url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Orgasm#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs trophoblastiques",
"description": "Peut-on prévenir les tumeurs trophoblastiques ?\nLe suivi après une grossesse est-il important ?\nLes antécédents familiaux influencent-ils le risque ?\nLes femmes ayant eu des grossesses multiples sont-elles à risque ?\nY a-t-il des recommandations pour les femmes enceintes ?",
"url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Orgasm#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs trophoblastiques",
"description": "Quels traitements sont disponibles ?\nLa chimiothérapie est-elle efficace ?\nQuand la chirurgie est-elle nécessaire ?\nY a-t-il des effets secondaires des traitements ?\nLa radiothérapie est-elle utilisée ?",
"url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Orgasm#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs trophoblastiques",
"description": "Quelles complications peuvent survenir ?\nLes tumeurs trophoblastiques peuvent-elles être mortelles ?\nComment les métastases se manifestent-elles ?\nLes complications affectent-elles la fertilité ?\nY a-t-il des risques psychologiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Orgasm#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs trophoblastiques",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge joue-t-il un rôle ?\nLes antécédents médicaux influencent-ils le risque ?\nLes habitudes de vie affectent-elles le risque ?\nLes facteurs environnementaux sont-ils impliqués ?",
"url": "https://questionsmedicales.fr/mesh/D014328?mesh_terms=Orgasm#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une tumeur trophoblastique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, échographies et biopsies."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de l'hormone chorionique gonadotrope (hCG) sont souvent mesurés."
}
},
{
"@type": "Question",
"name": "Les échographies sont-elles utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent de visualiser les masses et d'évaluer leur taille."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une tumeur trophoblastique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après une grossesse, si des symptômes anormaux ou des niveaux d'hCG élevés persistent."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'IRM pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM peut être utilisée pour évaluer l'extension des tumeurs dans certains cas."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des saignements vaginaux, douleurs abdominales et nausées."
}
},
{
"@type": "Question",
"name": "Les tumeurs trophoblastiques causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales peuvent survenir en raison de la pression exercée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, la fièvre et la perte de poids peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les nausées sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nausées peuvent être fréquentes, surtout en cas de tumeur avancée."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans grossesse récente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent apparaître même sans grossesse récente, nécessitant une évaluation."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs trophoblastiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical est conseillé."
}
},
{
"@type": "Question",
"name": "Le suivi après une grossesse est-il important ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier peut aider à détecter précocement des anomalies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de tumeurs trophoblastiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les femmes ayant eu des grossesses multiples sont-elles à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les grossesses multiples peuvent augmenter le risque de tumeurs trophoblastiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les femmes enceintes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi prénatal régulier est recommandé pour surveiller la santé maternelle et fœtale."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la surveillance."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie est souvent efficace pour traiter les tumeurs trophoblastiques."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle nécessaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est nécessaire si la tumeur est localisée et accessible."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme la fatigue, les nausées et la perte de cheveux peuvent survenir."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est rarement utilisée, sauf dans des cas spécifiques de métastases."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des saignements, des infections et des métastases."
}
},
{
"@type": "Question",
"name": "Les tumeurs trophoblastiques peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, si elles ne sont pas traitées, elles peuvent entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Comment les métastases se manifestent-elles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les métastases peuvent affecter les poumons, le foie et d'autres organes, causant divers symptômes."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la fertilité ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent affecter la fertilité future des femmes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques psychologiques associés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diagnostic et le traitement peuvent entraîner des troubles psychologiques chez les patientes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de grossesse molaires, les grossesses multiples et l'âge maternel avancé."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes de plus de 35 ans ont un risque accru de développer des tumeurs trophoblastiques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de tumeurs trophoblastiques augmentent le risque de récidive."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes, comme le tabagisme, peuvent influencer le risque de complications."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils impliqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent également jouer un rôle dans le développement de ces tumeurs."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA. Shahi.Maryam@mayo.edu.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Mayo Clinic, Rochester, MN, USA.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatric Surgery, Mayo Clinic, Rochester, MN, USA.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Dana-Farber Cancer Institute, MA, USA.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Dana-Farber Cancer Institute, MA, USA.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Dana-Farber Cancer Institute, MA, USA.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics, Gynecology, University of Missouri School of Medicine, Columbia, MO 65202, USA.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Hiroshima University, Hiroshima 7348551, Japan.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics, Gynecology, University of Missouri School of Medicine, Columbia, MO 65202, USA.
Division of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.
Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics, Gynecology, University of Missouri School of Medicine, Columbia, MO 65202, USA.
Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Immunopharmacology Laboratory, Institute of Biological Chemistry (IQUIBICEN), School of Exact and Natural Sciences, University of Buenos Aires-CONICET, Buenos Aires, Argentina.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Immunopharmacology Laboratory, Institute of Biological Chemistry (IQUIBICEN), School of Exact and Natural Sciences, University of Buenos Aires-CONICET, Buenos Aires, Argentina.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Immunopharmacology Laboratory, Institute of Biological Chemistry (IQUIBICEN), School of Exact and Natural Sciences, University of Buenos Aires-CONICET, Buenos Aires, Argentina.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, 171 64 Stockholm, Sweden. Electronic address: ulrika.joneborg@regionstockholm.se.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Institute of Reproductive Biology, Leibniz Institute for Farm Animal Biology (FBN), 18196, Dummerstorf, Germany.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Institute for Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), 18196, Dummerstorf, Germany.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Institute of Immunology, University of Rostock, 18057, Rostock, Germany.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Institute of Reproductive Biology, Leibniz Institute for Farm Animal Biology (FBN), 18196, Dummerstorf, Germany. fuerbass@fbn-dummerstorf.de.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
São Paulo Hospital Trophoblastic Disease Center, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Publications dans "Tumeurs trophoblastiques" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
Centre for Trophoblast Research, University of Cambridge, Cambridge CB2 3EG, UK.
Publications dans "Tumeurs trophoblastiques" :
The anatomy and physiology of the female orgasm are often neglected. The female orgasm is a normal psychophysiological function to all women, and some even can achieve ejaculation as part of the norma...
Orgasm, particularly in older women, remains a poorly understood aspect of female sexual response partly because of a lack of validated self-report measures....
To evaluate the Orgasm Rating Scale (ORS) and Bodily Sensations of Orgasm Scale (BSOS) for use with pre, peri, and post-menopausal women and between solitary and partnered orgasm contexts....
Participants (solitary context, 252 pre, 139 peri, 190 post; partnered context, 229 pre, 136 peri, and 194 post-menopausal women, aged 18-82 years) were asked to complete an online questionnaire based...
ORS and BSOS measuring solitary and/or masturbation and partnered orgasm....
For the ORS, 10 factor solutions were preferred, explaining 81% (pre), 80% (peri), and 81% (post) of the variance for the solitary and 83% (pre), 86% (peri), and 84% (post) of the variance for the par...
With valid measurement tools, women's varying orgasm experiences can be investigated more systematically and compared to address gaps and conflicts in the existing literature. Ultimately, these additi...
Strengths include gaining the ability to compare age and menopausal status groups using empirically validated measures of orgasm experience. Limitations include cross-sectional design and lack of test...
The ORS and BSOS are supported for use with women across adulthood in solitary and partnered orgasm contexts and can be used concurrently to provide a comprehensive assessment. Webb AE, Reissing ED, H...
Despite some efforts to enhance clitoral knowledge to increase women's sexual pleasure, a gendered orgasm gap persists. We aimed to provide contemporary data on people's knowledge about the clitoris a...
Orgasm is a phase of the human sexual response, and the possible discrepancies between male and female ways to experience it are still not clear in the literature. There is a lack of tools to adequate...
The subjective orgasm experience (SOE) is the psychological perception of orgasm sensations and closely related to sexual health. Here, SOE was studied through the context in which it is experienced (...
The increasing number of subjects with benign prostate obstruction (BPO) has become a worldwide concern. The sexual problem after benign prostate enlargement (BPE) surgery that has received the most a...
We evaluated the prospective, multicenter clinical data of 104 patients undergoing BPE surgery who reported maintaining sexual activity from January 2016 to November 2020. The endpoint of this study w...
Orgasm function was stable, improved, and degraded in 34% (n=35), 30% (n=31), and 36% (n=38) respectively. A deterioration in orgasm was statistically significant in men who maintained quality ejacula...
To enable the patient to maintain a satisfying and healthy sex life after any BPE surgery, urologist physicians should know the prevalence of orgasmic side effects after surgical treatment to provide ...
Grade 4....
The endogenous μ-opioid receptor (MOR) system plays a key role in the mammalian reward circuit. Human and animal experiments suggest the involvement of MORs in human sexual pleasure, yet this hypothes...
To assess the reported changes in orgasm quality and function of transgender men (TM) and transgender women (TW) after commencing gender-affirming hormone therapy (GAHT)....
We queried potential changes in orgasm function before and after commencing GAHT (minimum 1 year) among 130 consecutive TW and 33 TM. We queried the following domains under a uniform condition (mastur...
Within groups by gender, TW and TM reported similar responses to our inventory before starting GAHT. After commencing GAHT, TW reported notable changes in orgasm function: increase in lead-time necess...
GAHT has the potential to positively improve orgasm quality for transgender patients undergoing gender transition. It is important to share such data with patients prospectively before treatments....
In a confidential U.S. nationally representative survey of 2,525 adults (1300 women, 1225 men), we examined participants' event-level sexual behaviors, predictors of pleasure and orgasm, and perceived...
Postpartum pelvic floor dysfunction is known to affect the quality of life of women and the methods to treat it are more complex with majority requiring training under supervision....
To compare the efficacy of sexually induced orgasm along with Kegels exercises versus Kegels exercises alone as a treatment method to enhance postpartum pelvic floor muscle strength and sexual functio...
The prospective randomized two-arm study was conducted on sexually active primiparous women who had undergone uncomplicated vaginal deliveries. Those with risk factors for female sexual dysfunction an...
Postpartum pelvic floor strength and sexual function in 2 groups of women under study....
The study period was from January 2020 to December 2020. The Group 1 had 26 participants (mean age 29.69 ± 2.2 years) and Group 2 had 29 participants (mean age 30.07 ± 2.57 years). The sexual function...
Novel method of using naturally occurring sexually induced orgasms for postpartum pelvic floor rehabilitation can revolutionize postpartum pelvic floor training in women, as it can be practiced at hom...
Use of prospective randomization and minimization of confounding factors is the strength of the study. The small sample size is the limitation of the study....
Postpartum pelvic floor muscle strength and sexual function in primiparous women who have undergone uncomplicated vaginal deliveries can be significantly improved with the addition of sexually induced...